参考文献/References:
[1] SONG Pengkun, MAN Qingqing, LI Hong, et al. Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015[J]. Biomedical and Environmental Sciences, 2019, 32(8): 559-570.
[2] YANG Wenying, XIAO Jianzhong, YANG Zhaojun, et al. Serum lipids and lipoproteins in Chinese men and women[J]. Circulation, 2012, 125(18): 2212-2221.
[3] ZHANG Mei, DENG Qian, WANG Linhong, et al. Prevalence of dyslipidemia and achievement of lowdensity lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163 641 adults[J]. International Journal of Cardiology, 2018, 260: 196-203.
[4] NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol[J]. Nature, 2020, 582(7810): 73-77.
[5] DING Wenqing, CHENG Hong, YAN Yinkun, et al. 10-year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing, China[J]. Journal of Epidemiology, 2016,26(12): 637-645.
[6] 国家卫生健康委员会疾病预防控制局. 中国居民营养与慢性病状况报告 2020[M].北京:人民卫生出版社, 2020. National Health Commission, Disease Control and Prevention Administration. Report on the Nutrition and chronic diseases status of Chinese residents 2020[M]. Beijing: People’s Medical Publishing House, 2020.
[7] 王增武, 刘静, 李建军, 等. 中国血脂管理指南(2023年)[J]. 中国循环杂志,2023,38(3):237-271. WANG Zengwu, LIU Jing, LI Jiangjun, et al.Chinese guidelines for lipid management(2023) [J]. Chinese Circulation Journal,2023,38(3):237-271.
[8] BOR?N J, CHAPMAN M J, KRAUSS R M, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel[J]. European Heart Journal, 2020, 41(24): 2313-2330.
[9] 程俊杰, 李静, 梁西强, 等.非高密度脂蛋白胆固醇与冠心病患者心功能分级的相关性研究[J].现代检验医学杂志, 2016, 31(3): 43-47. CHENG Junjie, LI Jing, LIANG Xiqiang, et al. Correlation between non high density lipoprotein cholesterol and cardiac function in patients with coronary heart disease[J]. Journal of Modern Laboratory Medicine, 2016, 31(3): 43-47.
[10] 刘亚东, 王海晶, 王丽萍, 等. 延安市60 岁以上人群脑卒中危险因素调查分析[J]. 中华老年心脑血管病杂志, 2019, 21(9): 963-966. LIU Yadong, WANG Haijing, WANG Liping, et al. Risk factors for cerebral stroke in ≥ 60 years old Yan’an residents[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2019, 21(9): 963-966.
[11] 谭丽娟, 卢妍妍, 刘洋, 等. 柳州市柳北区成年居民慢性病相关行为因素分析[J]. 中华疾病控制杂志,2019, 23(7): 812-817. TAN Lijuan, LU Yanyan, LIU Yang, et al. Analysis on risk factor of chronic disease-related behaviors among adult residents in Liubei District, Liuzhou City[J]. Chinese Journal of Disease Control & Prevention, 2019, 23(7): 812-817.
[12] KO?TUNIUK A, ROSI?CZUK J. The influence of gender on selected risk factors for chronic noncommunicable diseases in patients hospitalized in surgical wards: A cross-sectional study[J]. Advances in Clinical and Experimental Medicine, 2018, 27(4): 515-523.
[13] PAN Ling, YANG Zhenhua, WU Yue, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China[J]. Atherosclerosis, 2016, 248: 2-9.
[14] BRUNNER F J, WALDEYER C, OJEDA F, et al. Application of non-HDL cholesterol for populationbased cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium[J]. Lancet, 2019, 394(10215): 2173-2183.
[15] BOEKHOLDT S M, ARSENAULT B J, MORA S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a metaanalysis[J]. JAMA, 2012, 307(12): 1302-1309.
[16] THANASSOULIS G, WILLIAMS K, YE Keying, et al. Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials[J]. Journal of the American Heart Association, 2014, 3(2):e000759.
[17] 仁晖, 陈红, 宋俊贤, 等.65 岁以上老年患者血脂水平及达标率随年龄变化的趋势[J].中华老年心脑血管病杂志, 2015, 17(7): 693-696. REN Hui, CHEN Hong, SONG Junxian, et al. Serum lipid level and its change with age in ≥ 65 years old patients[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2015, 17(7): 693-696.
[18] IQBAL J, AL QARNI A, HAWWARI A, et al. Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism[J]. Current Diabetes Reviews,2018, 14(5): 427-433.
[19] 范颖, 井丽, 田园梦, 等.2021 年沈阳市两城区≥ 60 岁老年人血脂异常情况及影响因素分析[J].中国公共卫生, 2023, 39(8): 991-995. FAN Ying, JING Li, TIAN Yuanmeng, et al. Prevalence and risk factors of dyslipidemia among elderly residents: a cross-sectional survey in two urban districts of Shenyang city, 2021[J]. Chinese Journal of Public Health, 2023, 39(8): 991-995.
[20] LIU Hongtao, DENG Xia, PENG Yudong, et al. Meta-analysis of serum non-high-density lipoprotein cholesterol and risk of coronary heart disease in the general population[J]. Clinica Chimica Acta, 2017, 471: 23-28.
[21] CAO Yanchao, YAN Liqiu, GUO Nan, et al. Nonhigh-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis[J]. Diabetes Research and Clinical Practice, 2019, 147: 1-8.
[22] VEKIC J, ZELJKOVIC A, STEFANOVIC A, et al. Obesity and dyslipidemia[J]. Metabolism, 2019, 92: 71-81.